Further, the expression of Glut5 and IL-6 was found to be positively corelated in clinical samples of OSCC, prostate cancer, colorectal cancer and glioma, suggesting that the IL-6-medited Glut5 expression probably widely exist in multiple human cancers. The gene discussed is IL6; the disease is prostate cancer.